Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UKKoen B. Pouwels, Andrew Walker, John I. Bell et al.|Nature Medicine|2021Cited by 564
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosisAdam Gregory, Lars Fugger, Calliope A. Dendrou et al.|Nature|2012Cited by 382
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccinesJia Wei, Helen Fryer, Koen B. Pouwels et al.|Nature Medicine|2022Cited by 268
Anti-spike antibody response to natural SARS-CoV-2 infection in the general populationJia Wei, David Bonsall, Philippa C. Matthews et al.|Nature Communications|2021Cited by 147